Drug recall · February 22, 2023
Maximum Zone2 Topical Analgesic recall
Why: cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Maximum Zone2 Topical Analgesic, 1oz bottle, for use during a pain sensitive procedure, distributed by: DERMAL SOURCE, Portland, OR, www.dermalsource.com, 1-866-568-3223, NDC code: 80069-012-01, Drug Facts- For use by licensed professionals only' Active Ingredients- Lidocaine HCL (5%), Epinephrine (0.01%).
- Lots / codes
Lot #: 795CP-0003, Exp 07/2024.
- Quantity
- 1,571 bottles
- Company
- HTO Nevada, Inc., Lake Oswego, OR
- Distribution
- Nationwide in the USA and Canada.
- Initiated
- February 9, 2023 · Voluntary: Firm initiated
- Classified
- February 15, 2023
- Reported
- February 22, 2023
- Ended
- November 17, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.